CRS+HIPEC

PROCEDURE3 trials

Sponsors

Yonsei University, CAI Hongbing, Sun Yat-sen University

Conditions

Chemotherapy EffectColorectal CancerColorectal Cancer MetastaticColorectal NeoplasmsCytoreductive SurgeryEpithelial Ovarian CancerGastric Cancer With Peritoneal Metastasis (PCI<12)Homologous Recombination Repair Gene Mutation

Phase 1

A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal Metastasis

CompletedNCT02995850

Yonsei UniversityGastric Cancer With Peritoneal Metastasis (PCI<12)

Start: 2017-02-22End: 2022-05-05Updated: 2023-08-08

Phase 2

Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases

Sun Yat-sen UniversityChemotherapy Effect, Colorectal Cancer, Colorectal Cancer Metastatic +6

Start: 2022-06-01End: 2025-07-01Target: 168Updated: 2022-04-29

Phase 3

A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation

CAI HongbingEpithelial Ovarian Cancer, Homologous Recombination Repair Gene Mutation, Hyperthermic Intraperitoneal Chemotherapy(HIPEC) +2

Start: 2020-08-01End: 2023-12-30Target: 280Updated: 2020-09-09